Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v2-FR | |
|---|---|---|
| Language (Changed) | Updated to: English | Was: French |
| Date Updated (Changed) | Updated to: 2026-02-10 | Was: 2026-02-04 |
| Drug Identification Number | 02526778 | 02526778 |
| Brand name | CAFFEINE CITRATE INJECTION USP | CAFFEINE CITRATE INJECTION USP |
| Common or Proper name | CAFFEINE CITRATE INJECTION USP | CAFFEINE CITRATE INJECTION USP |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | CAFFEINE CITRATE | CAFFEINE CITRATE |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 1 x 3 mL vial / fiole | 1 x 3 mL vial / fiole |
| Additional packaging sizes | ||
| ATC code | N06BC | N06BC |
| ATC description | ||
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2026-02-20 | 2026-02-20 |
| Estimated end date (Changed) | Updated to: 2026-03-13 | Was: 2026-03-23 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |